These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20032953)

  • 1. [Efficacy and tolerability of choline alphoscerate (cereton) in patients with Parkinson's disease with cognitive disorders].
    Levin OS; Batukaeva LA; Anikina MA; Iunishchenko NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(11):42-6. PubMed ID: 20032953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of cereton in the acute period of ischemic stroke].
    Ismagilov MF; Vasilevskaia OV; Gaĭfutdinov RT; Strakhova TM; Kuz'mina IA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(3):35-6. PubMed ID: 19365389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of cereton in patients with chronic brain ischemia and moderate cognitive impairment].
    Pizova NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(12):78-83. PubMed ID: 25726784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Memantine (akatinol) therapy of cognitive impairment in Parkinson's disease complicated by dementia].
    Litvinenko IV; Odinak MM; Mogil'naia VI; Perstenev SV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(10):37-42. PubMed ID: 19008850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Choline alphoscerate (ceretone) in the treatment of patients with chronic cerebral ischemia].
    Stulin ID; Musin RS; Solonskiĭ DS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(7):87-9. PubMed ID: 19708279
    [No Abstract]   [Full Text] [Related]  

  • 6. [The domestic drug cereton in the treatment of patients in the acute period of ischemic stroke].
    Shmyrev VI; Kryzhanovskiĭ SM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(12):53-6. PubMed ID: 19253468
    [No Abstract]   [Full Text] [Related]  

  • 7. [Efficacy of acatinol memantine in mild cognitive disorder].
    Levin OS; Iunishchenko NA; Dudarova MA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(7):36-42. PubMed ID: 19672236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of cereton in the rehabilitation of patients with hemorrhagic stroke].
    Buĭlova TV; Glotova ME; Khalak ME; Vashkevich VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5 Suppl 2):57-61. PubMed ID: 19894302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: interim results.
    Amenta F; Carotenuto A; Fasanaro AM; Rea R; Traini E
    J Neurol Sci; 2012 Nov; 322(1-2):96-101. PubMed ID: 22959283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Akatinol memantine in the therapy of cognitive disorders in Parkinson's disease].
    Puzin MN; Krivonos OV; Kozhevnikova ZhV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(1):26-9. PubMed ID: 17310793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of omaron in patients with post-stroke cognitive disorders].
    Parfenov VA; Belavina GR; Vakhnina NV; Gusev VV; Levin IaI; Markin SP; Starchina IuA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(6):41-5. PubMed ID: 19672226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choline alphoscerate (alpha-glyceryl-phosphoryl-choline) an old choline- containing phospholipid with a still interesting profile as cognition enhancing agent.
    Traini E; Bramanti V; Amenta F
    Curr Alzheimer Res; 2013 Dec; 10(10):1070-9. PubMed ID: 24156263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: an analysis of published clinical data.
    Parnetti L; Amenta F; Gallai V
    Mech Ageing Dev; 2001 Nov; 122(16):2041-55. PubMed ID: 11589921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical efficacy and safety of choline alfoscerate in the treatment of late-onset cognitive impairment].
    Gavrilova SI; Kolykhalov IV; Ponomareva EV; Fedorova YB; Selezneva ND
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(5):45-53. PubMed ID: 29927403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.
    Stocchi F; Rascol O; Destee A; Hattori N; Hauser RA; Lang AE; Poewe W; Stacy M; Tolosa E; Gao H; Nagel J; Merschhemke M; Graf A; Kenney C; Trenkwalder C
    Mov Disord; 2013 Nov; 28(13):1838-46. PubMed ID: 23853029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and cognitive profiles of patients with both Parkinson's disease and essential tremor.
    Ozen Barut B; Gunal DI; Turkmen C; Mollahasanoğlu A; Ankaralı H
    Acta Neurol Belg; 2013 Jun; 113(2):117-25. PubMed ID: 22926528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of amantadine sulfate on cognitive disorders in patients with Parkinson's disease].
    Iablonskaia AIu; Fedorova NV; Bel'gusheva ME
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(7):24-30. PubMed ID: 20639853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy and safety of galantamine (reminyl) in the treatment of dementia in patients with Parkinson's disease (open-label controlled trial)].
    Litvinenko IV; Odinak MM; Mogil'naia VI; Emelin AIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(12):25-33. PubMed ID: 18427456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical rehabilitative effect of memantine on cognitive and motor disorders in patients with Parkinson's disease].
    Li W; Zhao JH; Sun SG; Zhang JW; Suo AQ; Ma MM
    Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(5):301-3. PubMed ID: 21419002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of memantine in Parkinson's disease with dementia].
    Levin OS; Batukaeva LA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(12):16-23. PubMed ID: 19156121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.